HealthcareAscendis raised to outperform by Oppenheimer ahead of drug launchBy Helitra.com·September 7, 2024·1 min read Ascendis raised to outperform by Oppenheimer ahead of drug launch Source: SeekingalphaADVERTISEMENT ADVERTISEMENTahead Ascendis drug launch Oppenheimer outperform raised Post navigation Previous storyVor Bio stock rallies post-market on trem-cel study dataNext storyLisata jumps on FDA orphan drug status for liver cancer drug
Fitness · HealthcareGLP-1s Can Lower Lean Mass, But One Nutrient May HelpNovember 13, 2026If you’re taking a GLP-1 medication like semaglutide or tirzepatide, you may have noticed that you’re getting full faster and eating smaller meals.…
Fitness · HealthcareOzempic may reduce oxygen supply to developing fetuses, animal study findsNovember 13, 2026Researchers set out to check the safety of using weight loss jabs during pregnancy, and came across a worrying finding in their animal-based…
Fitness · HealthcareDoctor Explains Jennifer Lawrence’s Postpartum ClaimNovember 13, 2026Of all the things people warn you about childbirth, the fate of your butthole isn’t usually at the top of the list. Jennifer…